0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Regulatory T cells (Tregs) are essential in maintaining immune tolerance and controlling inflammation. Treg stability relies on transcriptional and post-translational mechanisms, including histone acetylation at the Foxp3 locus and FoxP3 protein acetylation. Additionally, Tregs depend on specific metabolic programs for differentiation, yet the underlying molecular mechanisms remain elusive. We aimed to investigate the role of acetyl-CoA carboxylase 1 (ACC1) in the differentiation, stability, and function of regulatory T cells (Tregs).

          Methods

          We used either T cell-specific ACC1 knockout mice or ACC1 inhibition via a pharmacological agent to examine the effects on Treg differentiation and stability. The impact of ACC1 inhibition on Treg function was assessed in vivo through adoptive transfer models of Th1/Th17-driven inflammatory diseases.

          Results

          Inhibition or genetic deletion of ACC1 led to an increase in acetyl-CoA availability, promoting enhanced histone and protein acetylation, and sustained FoxP3 transcription even under inflammatory conditions. Mice with T cell-specific ACC1 deletion exhibited an enrichment of double positive RORγt +FoxP3 + cells. Moreover, Tregs treated with an ACC1 inhibitor demonstrated superior long-term stability and an enhanced capacity to suppress Th1/Th17-driven inflammatory diseases in adoptive transfer models.

          Conclusions

          We identified ACC1 as a metabolic checkpoint in Treg biology. Our data demonstrate that ACC1 inhibition promotes Treg differentiation and long-term stability in vitro and in vivo. Thus, ACC1 serves as a dual metabolic and epigenetic hub, regulating immune tolerance and inflammation by balancing de novo lipid synthesis and protein acetylation.

          Graphical abstract

          Highlights

          • ACC1 inhibition, but not ACC2, results in elevated intracellular acetyl-CoA levels during Treg cell differentiation.

          • Increased acetyl-CoA levels drive global protein and histone acetylation enhancing histone acetylation at the Foxp3 locus.

          • Fatty acid inhibition promotes the induction and long-term stability of Tregs, even under inflammatory conditions.

          Related collections

          Most cited references94

          • Record: found
          • Abstract: found
          • Article: not found

          Regulatory T cells and immune tolerance.

          Regulatory T cells (Tregs) play an indispensable role in maintaining immunological unresponsiveness to self-antigens and in suppressing excessive immune responses deleterious to the host. Tregs are produced in the thymus as a functionally mature subpopulation of T cells and can also be induced from naive T cells in the periphery. Recent research reveals the cellular and molecular basis of Treg development and function and implicates dysregulation of Tregs in immunological disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

            On activation, T cells undergo distinct developmental pathways, attaining specialized properties and effector functions. T-helper (T(H)) cells are traditionally thought to differentiate into T(H)1 and T(H)2 cell subsets. T(H)1 cells are necessary to clear intracellular pathogens and T(H)2 cells are important for clearing extracellular organisms. Recently, a subset of interleukin (IL)-17-producing T (T(H)17) cells distinct from T(H)1 or T(H)2 cells has been described and shown to have a crucial role in the induction of autoimmune tissue injury. In contrast, CD4+CD25+Foxp3+ regulatory T (T(reg)) cells inhibit autoimmunity and protect against tissue injury. Transforming growth factor-beta (TGF-beta) is a critical differentiation factor for the generation of T(reg) cells. Here we show, using mice with a reporter introduced into the endogenous Foxp3 locus, that IL-6, an acute phase protein induced during inflammation, completely inhibits the generation of Foxp3+ T(reg) cells induced by TGF-beta. We also demonstrate that IL-23 is not the differentiation factor for the generation of T(H)17 cells. Instead, IL-6 and TGF-beta together induce the differentiation of pathogenic T(H)17 cells from naive T cells. Our data demonstrate a dichotomy in the generation of pathogenic (T(H)17) T cells that induce autoimmunity and regulatory (Foxp3+) T cells that inhibit autoimmune tissue injury.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

              IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease. We show here that the orphan nuclear receptor RORgammat is the key transcription factor that orchestrates the differentiation of this effector cell lineage. RORgammat induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naïve CD4(+) T helper cells and is required for their expression in response to IL-6 and TGF-beta, the cytokines known to induce IL-17. Th17 cells are constitutively present throughout the intestinal lamina propria, express RORgammat, and are absent in mice deficient for RORgammat or IL-6. Mice with RORgammat-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells. Together, these studies suggest that RORgammat is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Mol Metab
                Mol Metab
                Molecular Metabolism
                Elsevier
                2212-8778
                08 February 2025
                April 2025
                08 February 2025
                : 94
                : 102111
                Affiliations
                [1 ]Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, Germany
                [2 ]A Joint Venture Between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover 30625, Germany
                [3 ]Leibniz Institute for Immunotherapy, Regensburg, Germany
                [4 ]Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55122, Germany
                [5 ]Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany
                [6 ]Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba, Argentina
                [7 ]Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina
                [8 ]Department of Bioinformatics and Biochemistry, BRICS, Technische Universität Braunschweig, 38106 Braunschweig, Germany
                [9 ]Systems-Oriented Immunology and Inflammation Research Group, Department of Experimental Immunology, HZI, Braunschweig 38124, Germany
                [10 ]Institute for Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, Magdeburg 39106, Germany
                [11 ]Institute for Molecular Immunology, Ruhr-University Bochum, Bochum 44801, Germany
                [12 ]Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104, USA
                [13 ]Department of Chemical Microbiology, HZI, Braunschweig 38124, Germany
                [14 ]Research Core Unit Metabolomics, MHH, Hannover 30625, Germany
                [15 ]Institute of Medical Microbiology and Hospital Epidemiology, MHH, Hannover 30625, Germany
                [16 ]Sorbonne Université, INSERM, CNRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris 75013, France
                [17 ]Division of Nephrology and Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104, USA
                [18 ]Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
                [19 ]Research Center for Immunotherapy (FZI), University Medical Center Mainz, 55131 Mainz, Germany
                Author notes
                [* ]Corresponding author. Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany. berod@ 123456uni-mainz.de
                [20]

                Philipp Stüve and Gloria J. Godoy contributed equally.

                Article
                S2212-8778(25)00018-3 102111
                10.1016/j.molmet.2025.102111
                11893314
                39929287
                1cac6421-148b-421b-b46a-fda07adc88bd
                © 2025 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 30 January 2025
                : 6 February 2025
                Categories
                Original Article

                acc1,adoptive treg transfer,epigenetic regulation,fatty acid synthesis,treg stability,acetylation

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content98

                Most referenced authors2,030